Novel alternative PBX3 isoforms in leukemia cells with distinct interaction specificities

Area of Science:

• Molecular Biology
• Genetics
• Cancer Biology

Background:

• PBX3 is a TALE homeobox gene, part of a family including PBX1 and PBX2.
• While PBX1 expression is restricted, PBX2 and PBX3 are ubiquitously expressed.
• The functional role of PBX3 remains largely uncharacterized.

Purpose of the Study:

• To identify and characterize novel isoforms of PBX3.
• To investigate the expression patterns of these new isoforms in normal and cancerous cells.
• To explore the functional implications of these isoforms in PBX3-mediated transcriptional regulation.

Main Methods:

• Identification of novel PBX3 transcripts (PBX3C and PBX3D) through alternative splicing analysis.
• Detection of PBX3 isoform expression in various tissues and cell lines using molecular techniques.
• Functional studies assessing protein interactions of PBX3C and PBX3D with known partners like PREP1 and MEIS proteins.

Main Results:

• Two novel PBX3 isoforms, PBX3C and PBX3D, were identified, arising from alternative splicing.
• PBX3D expression is favored in normal cells, whereas PBX3C expression is favored in leukemia cells.
• PBX3C and PBX3D exhibit altered interactions with PREP1 and MEIS proteins compared to canonical PBX3.

Conclusions:

• The newly identified PBX3C and PBX3D isoforms possess distinct expression profiles correlating with cellular states (normal vs. leukemia).
• These isoforms may modulate PBX3's transcriptional activity by forming alternative protein complexes.
• This discovery provides a basis for understanding the diverse biological roles of PBX3 in normal physiology and disease.